KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Common Equity (2016 - 2025)

Merck (MRK) has disclosed Common Equity for 17 consecutive years, with $52.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 13.71% to $52.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $52.7 billion, a 13.71% increase, with the full-year FY2025 number at $52.7 billion, up 13.71% from a year prior.
  • Common Equity was $52.7 billion for Q4 2025 at Merck, up from $51.8 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $52.7 billion in Q4 2025 to a low of $27.0 billion in Q1 2021.
  • A 5-year average of $42.5 billion and a median of $43.5 billion in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 51.46% in 2022, then decreased 18.29% in 2023.
  • Merck's Common Equity stood at $38.3 billion in 2021, then rose by 20.39% to $46.1 billion in 2022, then dropped by 18.29% to $37.6 billion in 2023, then grew by 23.06% to $46.3 billion in 2024, then grew by 13.71% to $52.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Common Equity are $52.7 billion (Q4 2025), $51.8 billion (Q3 2025), and $49.1 billion (Q2 2025).